On the contrary, in ovarian cancer cells, the inhibitory effect of genistein and daidzein has been found to suppress cell migration through the downregulation of different migration-related pathways (i.e., FAK, PI3K/AKT), which implies a role in ERβ activation (Table 1) [131,134]. Here, ESR2 is linked to ovarian cancer.